| January 2010 |
Herceptin now approved in the EU for patients with HER2-positive advanced stomach cancer more..
Roche invests about 190 Mio Swiss Francs in infusion-free administration device with new Herceptin formulation more..
FDA approves ACTEMRA for the treatment of moderately to severely active rheumatoid arthritis more..
Xeloda® in combination with oxaliplatin filed in Europe for the adjuvant treatment of patients with early colon cancer more.. |
 |
| December 2009 |
Greater chances of cure for patients with HER2-positive early breast cancer when treated with one year of Herceptin more..
Avastin plus commonly used chemotherapies improves time without the disease getting worse in women with previously treated advanced breast cancer more..
Roche, Genentech and Biogen Idec announce positive results from first phase III trial of ocrelizumab in rheumatoid arthritis more..
Roche Introduces New Automated Clinical Laboratory System for CE-Marked Testing of Human Papillomavirus, Chlamydia and N. gonorrhoeae more..
Important progress in treatment of early and late stage breast cancer with Herceptin, Avastin and T-DM1 more..
MabThera/Rituxan is the first treatment to show improved overall survival in previously untreated patients with chronic lymphocytic leukemia more..
MabThera/Rituxan: promising new data in leukemia and lymphatic cancers to be presented at the American Society of Hematology (ASH), the world's leading meeting in blood cancers more.. |
|
| October 2009 |
ACTEMRA inhibits progression of joint destruction in RA patients by over 80% compared to methotrexate alone more..
Roche reports further accelerated sales growth in third quarter more.. |
|
| September 2009 |
Herceptin provides impressive survival benefit for patients with high levels of HER2 in their stomach cancer more..
From inoperable disease to potentially life saving surgery - new Avastin data gives hope to colorectal cancer patients with liver metastases more..
Roche announces results from two early studies which show promise for patients with malignant melanoma more..
Avastin could play an important role in improving the daily lives of patients with the most aggressive form of brain cancer more..
Two new studies report increased survival rates in Tamiflu-treated patients with avian flu (H5N1) and severe seasonal flu more..
Roche recognised as new Super Sector Leader in Dow Jones Sustainability Index more..
MabThera approved in Europe for use in patients with previously-treated chronic lymphocytic leukaemia more..
Roche receives CE Mark certification for cobas 8000 modular analyzer series more.. |
|
| August 2009 |
Avastin plus commonly used chemotherapies improves time without the disease getting worse in women with previously treated advanced breast cancer more..
Fragile X Syndrome: Translating knowledge into real therapies more..
Discussing the (as yet) untested business case behind PHC more..
Avastin approved in US for the most common type of kidney cancer more.. |
|
| July 2009 |
Second Phase III Study Showed Lucentis Improved Vision in Patients with Retinal Vein Occlusion more..
European commission approves broader label for Avastin allowing combination with docetaxel for the first-line treatment of advanced (metastatic) breast cancer more..
MabThera receives positive opinion in Europe for treating patients whose chronic lymphocytic leukaemia returns more..
Xeloda in combination with oxaliplatin shown to be effective in early colon cancer more..
PHC in Practice - Pharma and Diagnostics collaborate to prove medical value of new CMV test more..
New data from phase III SATURN study shows Tarceva improves overall survival when used immediately after initial chemotherapy in patients with advanced lung cancer more..
PHC in Practice - Roche improving HER2 testing for breast and gastric cancer more..
Phase III Study Showed Lucentis Improved Vision in Patients with Branch Retinal Vein Occlusion more.. |
|
| May 2009 |
Herceptin landmark study (ToGA) reveals unprecedented survival benefit in HER2-positive stomach cancer more..
Maintenance treatment with Avastin and Tarceva in combination helps lung cancer patients live longer without their disease worsening more..
Full results from first Phase III study of Avastin in adjuvant colon cancer announced more..
Two-year data reinforce effectiveness of ACTEMRA in inhibiting joint damage and improving physical function in patients with rheumatoid arthritis more..
Roche to present major advances with targeted cancer medicines at ASCO more..
Important New Treatment Option Approved in US for Patients with the Most Aggressive Form of Brain Cancer more.. |
|
| April 2009 |
Roche strongly outperforms market in first quarter more..
Roche Diabetes Care supports "Changing Diabetes in Children" more..
Roche to introduce new LightCycler MRSA Advanced Test in the EU more.. |
|
| March 2009 |
Herceptin now shown to significantly prolong the lives of patients with HER2-positive advanced stomach cancer more..
Roche acquires innovatis AG to complement its product portfolio in the rapidly growing area of cellular analytics more..
Roche and Genentech reach a friendly agreement to combine the two organizations and create a leader in healthcare innovation more..
Herceptin proven to benefit women with HER2 positive early breast cancer latest results from the HERA study more.. |
|
| February 2009 |
MabThera approved in the EU for patients with chronic lymphocytic leukaemia more..
For the first time, doctors can predict which hepatitis B patients have the highest chance to achieve treatment success with Pegasys more..
Strong operating results for Roche in 2008 more..
Avastin and Tarceva in combination significantly improves the time patients with advanced lung cancer can live without their disease worsening more.. |
|
| January 2009 |
Roche intends to commence tender offer to acquire all shares of Genentech for US$ 86.50 per share in cash more..
Roche delighted about pool extension more..
MabThera receives positive opinion in Europe for first-line treatment for chronic lymphocytic leukaemia more..
RoACTEMRA approved in Europe to treat patients suffering from Rheumatoid Arthritis more.. |
|
| December 2008 |
MabThera inhibits the destruction of joints in patients with early rheumatoid arthritis more..
Herceptin given prior to surgery improves the chance of survival without relapse for women with HER2-positive breast cancer more..
New data show that Herceptin, Xeloda and Avastin help patients with early and advanced breast cancer live longer or remain disease free for longer more..
New data from largest-ever clinical trials in CLL show MabThera enables leukaemia patients to live longer without their disease progressing more..
European Commission approval of new indication for Roche's Pegasys offers hepatitis C patients a second chance for a cure more..
Roche and FDA Agree on Pathway Towards U.S. Approval of Actemra (tocilizumab) more..
6th Roche Children's Walk: some 14'000 employees from 100 sites worldwide walk today to support children in need more.. |
|
| November 2008 |
Supporting modern standards of corporate governance more..
Roche signs definitive agreement to acquire Memory Pharmaceuticals more..
New phase III study of Avastin in advanced breast cancer meets its primary endpoint of increasing the time patients live without their disease getting worse more..
RoActemra Receives Positive Opinion in Europe for the Treatment of Rheumatoid Arthritis more..
Tarceva brings new hope to patients with advanced non-small cell lung cancer more..
Clinical studies as a logistical challenge more.. |
|
| October 2008 |
Roche posts sustained double-digit sales growth for the first nine months of 2008 more..
Pivotal Phase III study shows MabThera delays disease progression in patients with relapsed or refractory Chronic Lymphocytic Leukaemia more..
Roche announces topline outcomes for Avastin-Tarceva combination study in advanced lung cancer more..
Genentech, Glycart and Roche enter into collaboration agreement for potential cancer therapy more..
Roche invests 215 million Swiss francs in diagnostics facility at Penzberg more.. |
|
| September 2008 |
New data confirms Avastin as the only biologic to demonstrate overall survival when used first-line in metastatic colorectal cancer patients with K-RAS (wild-type) gene status more..
Roche to present data showing progress in treating lung, gastric and brain cancers at ESMO more.. |
|
| August 2008 |
Chocos Village Project: contributions from Roche make a difference more..
Parallel imports of patented drugs: a critical reflexion more..
Blood Screening Team Wins 'Gold' at Olympic Games more..
Roche and Meda agree on product transactions more..
Roche continues to believe its Genentech proposal is fair and generous more..
Roche Continents: creativity and innovation in Arts and Science more.. |
|
| July 2008 |
FDA Advisory Committee recommends approval of Actemra for the treatment of rheumatoid arthritis more..
Using a novel sequencing system within RNAi therapeutic research more..
Roche starts acquisition process of ARIUS to gain access to new screening platform for antibody therapeutics more..
Roche acquires Mirus to advance research in the field of RNAi delivery more..
Roche posts very good results: strong market outperformance - guidance confirmed more..
Experts in a dialogue on genetics and ethics more.. |
|
| June 2008 |
European approval for Roche`s Pegasys personalises treatment for a subgroup of hepatitis C patients: chance for cure with only four months of treatment more..
New data reveals Actemra is the first and only biologic drug to show superiority over current standard of care in rheumatoid arthritis more..
Roche moves investigational diabetes drug, Taspoglutide, into Phase III clinical trials more..
Animal protection plays an important role in innovative research more.. |
|
| May 2008 |
Study confirms that Avastin significantly increases chance of living without disease progression in metastatic breast cancer more..
Continuing Herceptin treatment prevents disease progression in women with aggressive metastatic breast cancer more..
Sustainability at Roche - an overview more..
New Global Roche Position: Pharmaceuticals in the Environment more.. |
|
| April 2008 |
Roche employees support gift charity for Indian children more..
Roche continues solid sales growth in first quarter of 2008 - both divisions significantly outpace their markets more..
Actemra approved in Japan to treat patients with rheumatoid arthritis more..
Alzheimer, a disease worth researching more..
Roche fully acquires privately-owned biotech company Piramed more.. |
|
| March 2008 |
Roche says drug for cholesterol does well in tests more..
New Roche Energy Efficiency Standard Translates Commitment Into Action more..
Developing a new generation of diagnostics systems more..
Roche raises dividend by 35 percent more.. |
|
| February 2008 |
Herceptin approved in Japan for early treatment in patients with HER2-positive breast cancer more..
FDA grants accelerated approval of Avastin in combination with paclitaxel chemotherapy for first-line treatment of patients with advanced HER2-negative breast cancer more..
Second phase III study of Avastin in 1st line metastatic breast cancer meets its primary endpoint more..
CNS Biomarker Day in Basel: bridging the gap between Pharma Research and Pharma Development more..
Conducting research experiments with great speed more.. |
|
| January 2008 |
Roche helps African, Asian companies make AIDS drug more..
Successful cooperation: from scientific breakthrough to therapy more.. |
|
| December 2007 |
| PCR - test method enriching medical diagnosis more.. |
|
| November 2007 |
| Roche arthritis drug effective in late-stage trial more.. |
|
| October 2007 |
Roche Considering Legal Options In Patent Litigation Case more..
Tarceva approved for lung cancer in Japan more..
European licence for Roche HIV drug Viracept re-established by European Commission more..
Pivotal Mircera study first to convert dialysis patients from frequent dosing directly to once every four weeks more..
Japanese Red Cross selects Roche as partner for nucleic acid screening of entire Japanese blood supply more.. |
